Accelerating high-throughput screening with FirePlex-384: An automatable, multiplex immunoassay using FirePlex Particle Technology

9 Aug 2021

In this poster, Abcam describes a new assay platform, FirePlex-384^®, which combines high-throughput screening with multiplexing.

Related Products

Abcam's proprietary FirePlex particle technology is ideal for multiplexing protein targets.

(0)

27 Mar 2026

26 Mar 2026

25 Mar 2026